EBSCO Health

What EBSCO Health does

EBSCO Health is the healthcare division of EBSCO Information Services, a privately held, family-owned company founded in 1944 and headquartered in Ipswich, Massachusetts. The division provides evidence-based clinical decision support solutions, shared decision-making resources, healthcare business intelligence, and peer-reviewed medical research information to physicians, nurses, allied health professionals, and healthcare research institutions globally. Its core product portfolio centers on DynaMed, DynaMedex, and Dynamic Health — clinical decision support platforms that deliver fast, accurate, and actionable answers at the point of care — supplemented by research databases (CINAHL Ultimate, MEDLINE Ultimate) and acquired clinical tools (GIDEON, Isabel, ViDAL Consult, Patient Education Reference Center).

The company's technology stack rests on a curated, peer-reviewed clinical knowledge base that has been built and maintained for decades, with DynaMed holding exclusive licensed rights to publish same-day summaries of New England Journal of Medicine articles. In February 2026, EBSCO Health launched Dyna AI Mode and Dyna AI, purpose-built generative AI interfaces that sit on top of the DynaMed, DynaMedex, and Dynamic Health platforms to provide evidence-grounded answers with source transparency. The company cites clinician survey data showing 80% trust in evidence-based AI-CDS tools, 89% believing AI-CDS will improve patient outcomes, and 75% of AI-CDS users reporting time savings of four or more minutes per patient encounter. AI capabilities are currently restricted in the European Union.

EBSCO Health operates a recurring institutional subscription revenue model sold through enterprise field sales to hospitals, health systems, and academic medical centers across 14+ countries. Pricing is quote-based and not publicly disclosed, with annual billing cadence. Distribution occurs via the EBSCOhost research platform and EBSCO Mobile App. The division is supported by strategic content partnerships (NEJM, AWHONN) and a technology integration partnership with clinical AI platform Avo. EBSCO Health is part of a parent organization employing 1,001-5,000 people and has never undergone an IPO or external acquisition, remaining under founding family ownership.

Name

EBSCO Health

Legal name

EBSCO Information Services

Website

https://health.ebsco.com

Company type

Private

Founded year

1944

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

EBSCO Health, the healthcare division of privately-held EBSCO Information Services, provides evidence-based clinical decision support platforms (DynaMed, DynaMedex, Dynamic Health), research databases, and AI-powered tools to physicians, nurses, allied health professionals, and healthcare institutions globally via enterprise subscriptions.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Systems

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Physicians (6211)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Patient Intake, Digital Registration & eForms (HLACAEAF)

Keywords

• Clinical decision support
• Evidence-based medicine
• Medical research databases
• Healthcare AI solutions
• Nursing clinical resources

Headquarters

HQ city

Ipswich

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Clinical Decision Support Subscriptions: EBSCO Health generates revenue through institutional subscriptions to clinical decision support platforms including DynaMed, DynaMedex, Dynamic Health, and research databases like CINAHL Ultimate and MEDLINE Ultimate

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

EBSCO Health provides evidence-based clinical decision support software platforms — including DynaMed, DynaMedex, and Dynamic Health — that deliver fast, actionable answers to clinicians at the point of care. Its portfolio also includes nursing/allied health research databases (CINAHL Ultimate, MEDLINE Ultimate), specialized clinical tools (GIDEON, Isabel, ViDAL Consult), patient education resources, and the AI-powered Dyna AI / Dyna AI Mode interface. Products are sold primarily as institutional subscriptions to hospitals, health systems, and academic medical centers worldwide.

Product overview

EBSCO Health is a portfolio of clinical decision support solutions organized around a core platform-plus-modules architecture. The primary offerings include DynaMed, DynaMedex, and Dynamic Health as the main clinical decision support platforms, supplemented by specialized tools like DynaMed Decisions, CINAHL Ultimate, and MEDLINE Ultimate for research. The portfolio also includes acquired and partner brands such as GIDEON, Isabel, Isabel Symptom Checker, Patient Education Reference Center, and ViDAL Consult. The recent Dyna AI and Dyna AI Mode additions represent AI-powered interfaces integrated across the core platforms. The portfolio serves physicians, nurses, allied health professionals, and patients through evidence-based content, shared decision-making resources, and healthcare business intelligence.

Differentiator

Problem solved

Functional benefit

Brands

• DynaMed: Clinical decision support solution providing fast, accurate and actionable answers at the point of care
• DynaMedex
• Dynamic Health
• Dyna AI Mode
• Dyna AI
• CINAHL Ultimate
• MEDLINE Ultimate

Products and services

• DynaMed Clinical decision support solution that provides fast, accurate, and actionable answers to clinical questions at the point of care for physicians and healthcare providers, with the only licensed same-day access to New England Journal of Medicine content.
• DynaMed Decisions Clinical decision support solution within the DynaMed suite focused on decision-making support for healthcare providers, supporting shared decision-making with patients.
• DynaMedex
• Dynamic Health
• Dyna AI
• CINAHL Ultimate
• MEDLINE Ultimate
• GIDEON
• Isabel
• Isabel Symptom Checker
• Patient Education Reference Center
• ViDAL Consult

Quantifiable outcome

• 80% of clinicians trust evidence-based AI tools
• +3 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN)coreStrategic or Co-development Partner · 8 June 2026EBSCO Clinical Decisions announced a strategic partnership with AWHONN at the 2026 AWHONN Convention to integrate AWHONN's clinical expertise into EBSCO's Dynamic Health platform. AWHONN subject matter experts will conduct clinical reviews of nursing skills content, ensuring resources remain aligned with current best practices and undergo annual re-evaluation. The partnership aims to provide frontline nurses with validated, evidence-based knowledge accessible through clinical workflows to standardize care delivery and improve patient outcomes.
• New England Journal of Medicine (NEJM)coreStrategic or Co-development Partner · 20 January 2026DynaMed entered into an agreement with the New England Journal of Medicine to publish summaries of select NEJM research articles in real time within its platform. DynaMed is the only clinical decision support solution with licensed rights to same-day access to NEJM articles, addressing the demand for rapid access to clinical information at the point of care. The summaries will be available via web on the homepage and within clinical topics on the same day the NEJM embargo is lifted.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Elsevier (ClinicalKey, ClinicalPath): Elsevier's ClinicalKey competes head-to-head with DynaMedex (which already combines DynaMed with Elsevier data) and offers clinical decision support plus drug/disease reference content to hospitals and academic medical centers.
• BMJ (BMJ Best Practice): BMJ Best Practice is a clinical decision support tool for physicians at the point of care, offering evidence-based summaries similar to DynaMed and used internationally across hospital systems.
• Wolters Kluwer (UpToDate, Lexicomp): UpToDate is the market-leading clinical decision support platform for physicians, directly competing with DynaMed across hospitals and health systems globally. Wolters Kluwer's clinical solutions also include Lexicomp for drug information, paralleling DynaMedex.
• Merative (Micromedex): Micromedex is a long-standing drug and disease reference solution used by hospitals and health systems, directly competing with the drug information capabilities of DynaMedex and ViDAL Consult.

Emerging players

• PEPID: PEPID offers evidence-based clinical decision support for clinicians across hospital and point-of-care settings, including drug and disease information, overlapping with EBSCO's clinical reference portfolio.
• VisualDx: VisualDx is an AI-driven clinical decision support system focused on differential diagnosis and image-based clinical decision making, used by hospitals and serving as an emerging alternative to EBSCO's Isabel diagnostic tool.
• Epocrates (athenahealth): Epocrates is a clinical reference app widely used by physicians for drug information and clinical content, overlapping with DynaMedex and ViDAL Consult for point-of-care drug and disease reference.
• OpenEvidence: OpenEvidence is an AI-powered clinical decision support tool for clinicians that synthesizes medical literature, representing an emerging AI-native competitor to Dyna AI Mode in the point-of-care evidence retrieval category.
• FDB (First Databank): First Databank provides drug knowledge and medication decision support solutions integrated into EHR workflows, directly competing with the clinical drug information capabilities within DynaMedex and ViDAL Consult.
• Atropos Health: Atropos Health offers AI-powered real-world evidence and clinical decision support tools that complement traditional CDS platforms, representing an emerging adjacency to EBSCO's evidence-based decision support portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/EBSCO
• YouTubeyoutube.com/user/ebscopublishing
• Facebookfacebook.com/EBSCOInfoServices
• LinkedInlinkedin.com/company/ebsco-information-services
• Instagraminstagram.com/ebscoinformationservices

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EBSCO Health